Recurrent Resp Papillomatosis Fdtn (EIN 521798693) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1992

Legal Domicile

Principal Officer

Bill Stern

Phone

4055969805

Tax Period

2024-11-01 to 2025-10-31

Recurrent Resp Papillomatosis Fdtn, founded in 1992, is a small nonprofit in the Unknown sector that reported $142K in total revenue in fiscal year 2024. Revenue fell 71% from the prior year — a significant decline worth monitoring. Expenses of $367K exceeded revenue, resulting in a 158% operating deficit.

Mission

The Recurrent Respiratory Papillomatosis Foundation (RRPF) was created to provide patient/family support, serve as an information resource for patients an practitioners, promote public awareness, and aid in the prevention, treatment, and cure of RRP.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $142,341

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $142,341

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $317,255

Other Expenses $367,381

TOTAL EXPENSES $367,381

Year-over-Year Comparison

	2024	2023	Change
Revenue	$142,341	$486,204	-0.7%
Expenses	$367,381	$453,791	-0.2%
Net Income	$-225,040	$32,413	-7.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
Kim McClellan	President	Officer	$0	$0	$0
Chris Neuberger	Treasurer	Officer	$0	$0	$0
Bill Stern	Director CFO	Officer	$0	$0	$0
Jim Tansey	Vice President	Officer	$0	$0	$0
Heather DeGortari	Secretary	Officer	$0	$0	$0
Amy Tichgelaar	Director	Officer	$0	$0	$0
Geoff Young	Director	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$142,341	$367,381	$366,451	$-225,040
2024	$486,204	$453,791	$589,878	$32,413
2023	$399,839	$303,662	$548,475	$96,177
2022	$305,788	$104,085	$459,924	$201,703

Recurrent Resp Papillomatosis Fdtn